These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7645989

  • 1. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M, Hitchcock CL, Molinolo A, Milenic DE, Colcher D, Martin EW, Hinkle GH, Schlom J.
    Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
    [Abstract] [Full Text] [Related]

  • 2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW.
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [Abstract] [Full Text] [Related]

  • 3. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D, Milenic DE, Ferroni P, Carrasquillo JA, Reynolds JC, Roselli M, Larson SM, Schlom J.
    J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
    [Abstract] [Full Text] [Related]

  • 4. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
    Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J.
    Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
    [Abstract] [Full Text] [Related]

  • 5. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
    DePalatis LR, Johnson KA, Kaplan DA.
    Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661
    [Abstract] [Full Text] [Related]

  • 6. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A, Simpson JF, Thor A, Schlom J.
    Cancer Res; 1990 Feb 15; 50(4):1291-8. PubMed ID: 2297774
    [Abstract] [Full Text] [Related]

  • 7. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
    Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P.
    Cancer Res; 1988 Aug 15; 48(16):4588-96. PubMed ID: 3396010
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG, Verschraegen CF, Murray JL, Kudelka AP, Gano J, Cheung L, Kavanagh JJ.
    Clin Cancer Res; 1999 May 15; 5(5):953-61. PubMed ID: 10353726
    [Abstract] [Full Text] [Related]

  • 11. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
    Mangili F, Sassi I, Di Rocco M, Leone BE, Garancini P, Santambrogio G.
    Cancer; 1996 Dec 01; 78(11):2334-9. PubMed ID: 8941003
    [Abstract] [Full Text] [Related]

  • 12. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
    Simpson J, Schlom J.
    Yale J Biol Med; 1988 Dec 01; 61(4):351-66. PubMed ID: 3055701
    [Abstract] [Full Text] [Related]

  • 13. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
    Kuroki M, Fernsten PD, Wunderlich D, Colcher D, Simpson JF, Poole DJ, Schlom J.
    Cancer Res; 1990 Aug 15; 50(16):4872-9. PubMed ID: 1696162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
    Clemo FA, DeNicola DB, Zimmermann JL.
    Am J Vet Res; 1994 Aug 15; 55(8):1139-47. PubMed ID: 7978655
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity.
    Soomro S, Shousha S.
    Arch Pathol Lab Med; 1992 Jan 15; 116(1):32-5. PubMed ID: 1370877
    [Abstract] [Full Text] [Related]

  • 19. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.
    Horan Hand P, Colcher D, Salomon D, Ridge J, Noguchi P, Schlom J.
    Cancer Res; 1985 Feb 15; 45(2):833-40. PubMed ID: 3881173
    [Abstract] [Full Text] [Related]

  • 20. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
    Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J.
    Cancer Res; 1988 Aug 15; 48(16):4597-603. PubMed ID: 3396011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.